Switzer TV

 

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

With tech stocks sold off, resources rotating back into favour, and AI fears dominating headlines, each guest lays out what they’d actually buy now and why.

Adam Dawes kicks things off by explaining why selective commodities, developers and beaten-up growth names are back on the radar, and where investors need to be careful.

Jun Bei Liu then shares her “buy low” Christmas gift ideas, focusing on high-quality growth companies that have fallen out of favour but continue to grow earnings. Finally, Paul Rickard wraps up the year with a pragmatic take on oversold tech, patience, and which names could reward investors willing to look past short-term fear.

Interview timecodes:

00:01:01 - Adam Dawes, Shaw and Partners

00:17:41 - Jun Bei Liu, TenCap

00:25:37 - Paul Rickard, Switzer Report

 

This is our last show for 2025. We thank you for joining us and we'll see you on 10 January, 2026 with a new year of Switzer Investing TV.

Switzer Investing TV (15/12/25): What would our experts invest in now for growth in 2026?

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

More videos

Mad about Money

Peter Switzer shares his thoughts on the major current affairs impacting financial markets and the economy.

Series:
Is mobile phone use associated with an increased risk for brain cancer? | The Check Up

There have always been rumours on whether mobile phones are really linked with an increased risk for brain cancer. In this week's episode, Dr Ross looks at certain studies to assess this claim.

Series:
Michael Wayne on these stocks & more; TYR, APX, DDR + What's going on in the housing market?

Peter Switzer is joined by Michael Wayne of Medallion Financial, ST Wong of Prime Value, and CEO of Rate Money, Ryan Gair.

Series:
Are we heading for a recession? + Expert analysis on these 7 stocks!

Peter Switzer is joined by Michael Gable of Fairmont Equities, and Marcus Bogdan of Blackmore Capital.

Series:
A promising male contraception pill with zero effects on hormones?! | The Check Up

Currently, the only form of male contraception is a condom and a vasectomy. However, through certain studies and research conducted with mice, we may soon see a contraception pill for males with no hormonal effects.

Series:
Mad about Money

3 reasons why Dr Phil better be careful about raising interest rates & could stocks slide tomorrow?

Series:
5 quality stocks; GMG, ANZ, XRO, JBH & S32 + Should we fear the fed interest rate decision?

Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Anthony Doyle from Firetrail Investments and Paul Rickard is joined by Angus Moore from Proptrack.

Series:
What is immunotherapy and how does it fight cancer? | The Check Up

Dr Ross explains whether immunotherapy could be the new approach that could lead to an effective treatment for various types of cancer.

Series:
4 mid-cap stocks for your portfolio + How do you renovate or build and stay within your budget?

Paul Rickard is joined by Rudi Filapek-Vandyck of FNArena, Raymond Chan of Morgans, and Anna Porter from Suburbanite.

Series:
Mad about Money

US inflation disappoints & Wall Street tanks + Star Entertainment: 'Unfit to hold casino license'.

Series:
Why are copper, nickel and lithium stocks on the rise? + 3 growth companies; DGL, PPE & SMP

Paul Rickard is joined by Michael Wayne of Medallion Financial, Adam Dawes of Shaw and Partners, and Ron Shamgar of Tamim Asset Management.

Series:
Can a high dose of vitamin E really cause death? | The Check Up

Dr Ross has a look at whether a high dose of vitamin E can actually lead to death, as some studies show.

Series:
1 9 10 11 12 13 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram